About J. William Freytag
J. William Freytag, Ph.D., is an independent board member of Araceli Biosciences Inc., a company that works on faster and easier drug discovery.
He previously served as chairman and chief executive officer of Aspreva Pharmaceuticals and as president and chief executive officer of Myogen, Inc. He studied biochemistry, earning a Ph.D. from the University of Kansas Medical Center, after a bachelor's degree from Purdue University.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name J. William Freytag in the role, so the role may have started earlier or lasted longer.
Araceli Biosciences Inc. Current
Independent Board Member
2023 – Present · Tigard, OR
Araceli Biosciences makes high-content imaging and AI analysis systems that help drug discovery labs screen compounds faster.
AP
Aspreva Pharmaceuticals
Chairman and CEO
MI
Myogen, Inc.
President and CEO
Key Colleagues at Startups
The people J. William Freytag works with at each company, as listed on that company's latest Form D.
Araceli Biosciences Inc. · Form D, Nov 3, 2026
Matt Beaudet
President and CEO, director
WC
William Cortelyou
Chairman of the Board
Kirk Malloy
Director
Sean O'Neill
Director
SR
Samraat Raha
Director
Bruce Rhine
Director
Christine Ann Tsingos
Director